RxDoctor Payments Data

Taryn Murray, MD

Procedural Dermatology · Cleveland, OHNPI 1134624505

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.7% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 30.7% of the total. Reporting peaked in 2022 at $669 and has fallen 64.9% since, to $235 in 2025.

$2,312in general payments, 2019–2025

Across 55 payments — averaging $42.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$709
  • Sanofi$338
  • Regeneron Healthcare Solutions, Inc.$220
  • Galderma Laboratories, L.p.$220
  • Solta Medical, A Division Of Bausch Health US, LLC$196
  • Amgen$190
  • plus $439 from 5 others

What the payments were for

  • Food & beverage$2,16794%
  • Education$1456%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Ohioto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$9,061
Medicare patients
83
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab13$79,511
Dupixent SyringeDupilumab12$40,363
Doxycycline Monohydrate17$2,189
Clobetasol Propionate44$1,282
Triamcinolone Acetonide68$851
Ketoconazole60$734
Doxycycline Hyclate28$482
Mupirocin18$183
ValacyclovirValacyclovir Hcl19$150
Hydrocortisone30$142
Prednisone13$12

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →